U034 Advances in Microneedling Techniques Around the World
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The session aims to present updated, evidence-based practices and clinical pearls with a global perspective, using microneedling and other needling procedures in a safe and effective way to manage various common dermatoses. Conditions to be reviewed may include scars of various etiologies, striae distensae, androgenetic alopecia and rhytides. The use of microneedling to facilitate transdermal drug delivery will additionally be reviewed. Microneedling and radiofrequency microneedling will be compared and discussed. Topics to be presented will include assessment approaches, supporting recent literature, clinical pearls and experiences, and discussion of adverse effects and management options.
LEARNING OBJECTIVES
Demonstrate the safe and effective use of microneedling in patients with various common dermatoses as performed in real-world clinical practice
Evaluate evidence-based practices using microneedling (vs. radiofrequency microneedling) for scars, striae and rhytides based on clinical experience and research
Formulate approaches and treatment plans that optimizes outcomes and minimize adverse effects, when targeting aesthetic and medical skin needs of patients using microneedling across the skin spectrum
SCHEDULE
3:30 PM
Welcome and introductions
Monica Ka Yi Li, MD, FAAD, Tina S. Alster, MD, FAAD
3:32 PM
Microneedling for scars and straie: Pearls from India
Jaishree Sharad, DDV, MBBS, MD, IFAAD
3:43 PM
Microneedling and transdermal drug delivery: Perspectives from Thailand
Rungsima Wanitphakdeedecha, MD, IFAAD
3:54 PM
Comparing microneedling vs. radio frequency microneedling: Experiences treating skin of color
Robyn D. Siperstein, MD, FAAD
4:05 PM
Microcoring: Updates and clinical applications
4:16 PM
Panel discussion with Q&A
SPEAKERS
Tina S. Alster, MD, FAAD
Rishi Chopra, MD, MS, FAAD
Monica Ka Yi Li, MD, FAAD
Jaishree Sharad, DDV, MBBS, MD, IFAAD
Robyn D. Siperstein, MD, FAAD
Rungsima Wanitphakdeedecha, MD, IFAAD
SPEAKER DISCLOSURES
Tina S. Alster, MD, FAAD
A Method – Consultant(Other Financial Benefit); Collagen P.I.N. – Advisory Board(No Compensation Received); Hair Sanity – Stockholder(Stock); Home Skinovations – Consultant(Stock);
Rishi Chopra, MD, MS, FAAD
Accure, Inc – Consultant(Fees); Cynosure – Consultant (1099 relationship)(Equipment); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria);
Monica Ka Yi Li, MD, FAAD
AbbVie – Consultant(Honoraria); Allergan, Inc – Consultant(Honoraria); Bausch Health – Consultant(Honoraria), Speaker(Honoraria); Beiersdorf, Inc. – Consultant(Honoraria), Speaker(Honoraria); Candela Corporation – Consultant(Honoraria), Other(Equipment), Speaker(Honoraria); Endo Pharmaceuticals – Advisory Board(Honoraria); Galderma Canada, Inc – Speaker(Non-accredited CME Education Grant); Galderma Global – Advisory Board(Honoraria); Johnson and Johnson – Advisory Board(Honoraria), Consultant(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Speaker(Honoraria); Pfizer Inc. – Consultant(Honoraria), Speaker(Honoraria); Pierre Fabre – Speaker(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Shiseido, Inc. – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);
Jaishree Sharad, DDV, MBBS, MD, IFAAD
No financial relationships exist with ineligible companies.
Robyn D. Siperstein, MD, FAAD
Allergan – Consultant (1099 relationship)(Fees); Allergan, Inc – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Galderma USA – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Sciton Inc. – Speaker(Fees), Stockholder Private Company(Stock);
Rungsima Wanitphakdeedecha, MD, IFAAD
No financial relationships exist with ineligible companies.